Immunohistochemical characterization showed an intense positive response to Bcl-2 and Bcl-xL in choroid plexus tumors, primitive neuroectodermal tumors (PNETs), and neuroblastomas. This evidence concerns the gene BCL2L1 and neuroblastoma.